Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating expenses | $500.0K3 | $500.0K3 | |||
| Operating income | -$4.1M3 | -$2.5M3 | |||
| Interest | $3.6M3 | ||||
| Income before tax | $2.5M3 | -$544.0K3 | |||
| Income tax | $61.3K3 | ||||
| Net income | $2.5M3 | -$605.3K3 | |||
| Earnings per share | $0.103 | -$0.053 | |||
| Earnings per share (diluted) | $0.103 | -$0.053 | |||
| Shares (weighted, basic) | 24.1M shares3 | 12.2M shares3 | |||
| Shares (weighted, diluted) | 24.1M shares3 | 12.2M shares3 |
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Cash | $3.1M7 | $395.2K3 | $19.8K3 | ||
| Current assets | $3.8M6 | $414.1K3 | $68.6K3 | ||
| Total assets | $207.0M6 | $203.7M3 | $53.9M3 | ||
| Accounts payable | $47.7K3 | $226.8K3 | |||
| Current liabilities | $1.6M6 | $2.2M3 | $41.0M3 | ||
| Total liabilities | $19.4M6 | $13.4M3 | $50.7M3 | ||
| Retained earnings | -$13.1M3 | -$16.2M3 | |||
| Shareholders’ equity | -$15.6M3 | -$13.0M3 | -$16.2M3 | ||
| Shares outstanding | 5.0M shares6 | 5.0M shares3 | 5.0M shares3 | 6.6M shares8 | 6.6M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare Viveon Health Acquisition Corp. with another company
Corporate structure
Viveon Health Acquisition Corp. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Viveon Health Acquisition Corp.
- METEORA CAPITAL, LLC Filed SC 13G/A on Viveon Health Acquisition Corp., latest Nov 14, 2024 (4 filings since Feb 10, 2023)
- FIR TREE CAPITAL MANAGEMENT LP Filed SC 13G/A on Viveon Health Acquisition Corp., latest Feb 14, 2024 (2 filings since Feb 14, 2023)
- Polar Asset Management Partners Inc. Filed SC 13G/A on Viveon Health Acquisition Corp., latest Feb 12, 2024 (2 filings since Feb 10, 2023)
- Lawrence Feis Filed SC 13G/A on Viveon Health Acquisition Corp., latest Nov 14, 2022 (2 filings since Jul 29, 2022)
- Karpus Management, Inc. Filed SC 13G/A on Viveon Health Acquisition Corp., latest Apr 8, 2022 (2 filings since Feb 14, 2022)
- MMCAP International Inc. SPC Filed SC 13G/A on Viveon Health Acquisition Corp., latest Feb 4, 2022
- Weiss Asset Management LP Filed SC 13G/A on Viveon Health Acquisition Corp., latest Jan 28, 2022
- Viveon Health Acquisition Corp. Atlanta, Georgia
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Viveon Health Acquisition Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Leadership
Who has led Viveon Health Acquisition Corp., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerJagi Gill Dec 28, 2020 to Apr 8, 20219
- PresidentJagi Gill Dec 28, 2020 to Apr 8, 20219
- Chief financial officerRomilos Papadopoulos Jan 4, 2021 to Apr 8, 202110
Board members and other officers (5)
- Board memberRomilos Papadopoulos Jan 4, 2021 to Apr 8, 202110
- Board memberDemetrios G. Logothetis May 12, 2021 to Jun 4, 202111
- Board memberBrian J. Cole Dec 23, 2020 to Dec 28, 202012
- Board memberJagi Gill Dec 28, 2020 to Apr 8, 20219
- Board memberLishan Aklog Dec 28, 2020 to Dec 28, 202013
Timeline
- Oct 4, 20248-K Financial statements and exhibits14
- Jul 19, 20248-K Listing notice or transfer15
- Jun 5, 20248-K Entered a material agreement; New debt or obligation16
- Apr 1, 20248-K Shareholder vote; Other events17
- Mar 27, 20248-K Entered a material agreement18
- Feb 27, 20248-K Listing notice or transfer; Regulation FD disclosure19
- Jan 5, 20248-K Earlier financial statements no longer reliable20
- Dec 29, 20238-K Shareholder vote21
- Dec 26, 20238-K Listing notice or transfer22
- Nov 22, 20238-K Earlier financial statements no longer reliable23
- Aug 29, 20238-K Entered a material agreement; Regulation FD disclosure24
- Jun 27, 20238-K Shareholder vote; Other events25
- Dec 28, 2020New chief executive Jagi Gill becomes CEO9
Filings
118 filings to the SEC since October 2021: 6 annual reports, 7 quarterly reports, 29 major events, 14 large holders, 62 other. The latest 20:
- Mar 14, 202515-12G EDGAR
- Nov 14, 2024SC 13G/A EDGAR
- Oct 4, 20248-K EDGAR
- Jul 19, 2024425 EDGAR
- Jul 19, 20248-K EDGAR
- Jun 6, 202410-Q EDGAR
- Jun 5, 2024425 EDGAR
- Jun 5, 20248-K EDGAR
- May 30, 2024NT 10-Q EDGAR
- Apr 1, 2024425 EDGAR
- Apr 1, 20248-K EDGAR
- Mar 29, 2024NT 10-K EDGAR
- Mar 27, 2024425 EDGAR
- Mar 27, 20248-K EDGAR
- Mar 4, 2024UPLOAD EDGAR
- Mar 1, 2024DEF 14A EDGAR
- Feb 27, 2024425 EDGAR
- Feb 27, 20248-K EDGAR
- Feb 23, 2024PRER14A EDGAR
- Feb 21, 202410-K/A EDGAR
The 118 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- METEORA CAPITAL, LLCSC 13G/A, 4 filings Feb 10, 2023 to Nov 14, 202426
- FIR TREE CAPITAL MANAGEMENT LPSC 13G/A, 2 filings Feb 14, 2023 to Feb 14, 202427
- Polar Asset Management Partners Inc.SC 13G/A, 2 filings Feb 10, 2023 to Feb 12, 202428
- Lawrence FeisSC 13G/A, 2 filings Jul 29, 2022 to Nov 14, 202229
- Karpus Management, Inc.SC 13G/A, 2 filings Feb 14, 2022 to Apr 8, 202230
- MMCAP International Inc. SPCSC 13G/A, 1 filing Feb 4, 202231
- Weiss Asset Management LPSC 13G/A, 1 filing Jan 28, 202232
SEC filer profile
How Viveon Health Acquisition Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARViveon Health Acquisition Corp.1
- CIK0001823857
- Filer status<br>emerging growth company1
- Fiscal year endsDecember 311
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address3480 Peachtree Road Ne, 2Nd Floor - Suite #112, Atlanta, GA 303261
- Phone40457979781
- Shares outstanding5,656,160 as of Jun 6, 20245
- Public float$103.2M as of Jun 30, 20223
- On EDGAR sinceSep 10, 20201
- Filings173 in all: 8-K (36), 425 (19), 4 (11), SC 13G/A (10), NT 10-Q (9), SC 13G (9), 10-Q (8), CORRESP (8)1
All 34 form types
UPLOAD (8), 3 (7), 10-K/A (5), DEF 14A (5), PRE 14A (4), 10-K (3), 4/A (3), NT 10-K (3), S-4/A (3), 10-Q/A (2), 25-NSE (2), 424B3 (2), EFFECT (2), PRER14A (2), 15-12G (1), 25-NSE/A (1), 424B4 (1), 8-A12B (1), CERT (1), DEFA14A (1), DRS (1), RW (1), S-1 (1), S-1/A (1), S-1MEF (1), S-4 (1)
- Latest filingsAnnual report (10-K) Aug 24, 2023
Quarterly report (10-Q) Jun 6, 2024
Proxy statement (DEF 14A) Mar 1, 2024
Latest 8-K (8-K) Oct 4, 2024
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARJagi Gill, Chief executive officer
- 10
- 11
- 12SEC EDGARBrian J. Cole, Board member
- 13SEC EDGARLishan Aklog, Board member
- 14SEC EDGARFinancial statements and exhibits
- 15SEC EDGARListing notice or transfer
- 16
- 17SEC EDGARShareholder vote; Other events
- 18SEC EDGAREntered a material agreement
- 19
- 20
- 21SEC EDGARShareholder vote
- 22SEC EDGARListing notice or transfer
- 23
- 24
- 25SEC EDGARShareholder vote; Other events
- 26
- 27
- 28
- 29
- 30
- 31
- 32